Position in INCY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$467,469,320
+$98,513,650 QoQ
Shares Held
4,123,759
+5.2% QoQ
Ownership
2.06%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#9
of 854 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. INCY ranks #2 (24.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
2,275,145 | $548,241,690 | |
| 2 | INCY |
Incyte Corp
This page
|
4,123,759 | $467,469,320 | |
| 3 | EXEL |
Exelixis, Inc.
|
8,146,478 | $443,249,867 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
253,200 | $157,880,328 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
1,410,257 | $110,380,815 | |
| 6 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,061,242 | $75,049,821 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
881,700 | $50,450,874 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
721,666 | $28,231,573 |
All Filings in INCY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $467,469,320 | 4,123,759 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $368,955,670 | 3,920,056 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $388,537,277 | 3,933,758 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $338,060,886 | 3,986,097 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $262,990,691 | 3,861,831 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $220,279,325 | 3,637,974 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $239,499,534 | 3,467,490 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $193,237,401 | 2,923,410 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $167,910,853 | 2,769,892 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $156,939,645 | 2,754,777 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $169,019,817 | 2,691,827 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $70,828,041 | 1,226,035 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $73,388,703 | 1,178,935 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $86,155,596 | 1,192,135 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $96,274,363 | 1,198,635 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $71,509,051 | 1,073,065 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $995,207 | 13,100 | Shares | Sole | 2022-08-10 | |
| No filing history on record for this holder in this stock. | ||||||